Nhat H, Ibrahim R, Mouhaffel R, Abdelnabi M, et al. SGLT2 Inhibitors and Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospective Cohort Study. Am J Med 2025 Jun 24:S0002-9343(25)00410-3. doi: 10.1016/j.amjmed.2025.
PMID: 40571041